Literature DB >> 18332664

Genes and structural brain imaging in schizophrenia.

Neeltje E van Haren1, Steven C Bakker, René S Kahn.   

Abstract

PURPOSE OF REVIEW: Schizophrenia is a complex genetic disorder, caused by multiple genetic and environmental factors. Recently, studies have focused on testing specific genetic markers in a known candidate gene for association with endophenotypes. These are measurable characteristics of a disorder that are assumed to be closer to the action of the gene, resulting in higher genetic signal-to-noise ratios. Structural brain parameters have been shown to be useful endophenotypes for studies in psychiatric illnesses. RECENT
FINDINGS: After reviewing the available studies on the influence of genotype on brain volume in schizophrenia, it is evident that the BDNF and COMT genes are clearly favourites for genetic imaging studies. Results from these studies seem to be quite consistent, with the same associated alleles and direction of brain volume changes. The most frequently investigated polymorphisms suggest that sample sizes of approximately 50-100 patients are sufficient to report consistent findings. Considering the ongoing discussion about the sample size necessary to detect significant associations, however, larger sample sizes are needed.
SUMMARY: There is sufficient evidence to defend the use of structural neuroimaging as an endophenotype to investigate a complex phenotype such as schizophrenia despite the notion that, so far, no single causal pathway emerges from these studies. Replication studies and larger numbers of patients are essential in this respect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332664     DOI: 10.1097/YCO.0b013e3282f4f25b

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  23 in total

1.  Heritability of volumetric brain changes and height in children entering puberty.

Authors:  Inge L C van Soelen; Rachel M Brouwer; G Caroline M van Baal; Hugo G Schnack; Jiska S Peper; Lei Chen; René S Kahn; Dorret I Boomsma; Hilleke E Hulshoff Pol
Journal:  Hum Brain Mapp       Date:  2011-12-03       Impact factor: 5.038

Review 2.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 3.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

4.  Functional MRI at the crossroads.

Authors:  John Darrell Van Horn; Russell A Poldrack
Journal:  Int J Psychophysiol       Date:  2008-11-18       Impact factor: 2.997

5.  Post-traumatic stress disorder risk and brain-derived neurotrophic factor Val66Met.

Authors:  Lei Zhang; Xiao-Xia Li; Xian-Zhang Hu
Journal:  World J Psychiatry       Date:  2016-03-22

6.  Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.

Authors:  Ashley J Szabo; Michael L Alosco; Lindsay A Miller; John E McGeary; Athena Poppas; Ronald A Cohen; John Gunstad
Journal:  Psychogeriatrics       Date:  2013-10-28       Impact factor: 2.440

7.  Heritability estimates for cognitive factors and brain white matter integrity as markers of schizophrenia.

Authors:  Hilary Bertisch; Dawei Li; Matthew J Hoptman; Lynn E Delisi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

Review 8.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

Review 9.  The changing impact of genes and environment on brain development during childhood and adolescence: initial findings from a neuroimaging study of pediatric twins.

Authors:  Rhoshel K Lenroot; Jay N Giedd
Journal:  Dev Psychopathol       Date:  2008

10.  Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.

Authors:  Peixiong Yuan; Rulun Zhou; Yun Wang; Xiaoxia Li; Jianling Li; Guang Chen; Xavier Guitart; Husseini K Manji
Journal:  J Affect Disord       Date:  2009-11-13       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.